![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 13633 |
FusionGeneSummary for FN1_CDKN1B |
![]() |
Fusion gene information | Fusion gene name: FN1_CDKN1B | Fusion gene ID: 13633 | Hgene | Tgene | Gene symbol | FN1 | CDKN1B | Gene ID | 2335 | 1027 |
Gene name | fibronectin 1 | cyclin dependent kinase inhibitor 1B | |
Synonyms | CIG|ED-B|FINC|FN|FNZ|GFND|GFND2|LETS|MSF|SMDCF | CDKN4|KIP1|MEN1B|MEN4|P27KIP1 | |
Cytomap | 2q35 | 12p13.1 | |
Type of gene | protein-coding | protein-coding | |
Description | fibronectincold-insoluble globulinmigration-stimulating factor | cyclin-dependent kinase inhibitor 1Bcyclin-dependent kinase inhibitor 1B (p27, Kip1) | |
Modification date | 20180527 | 20180523 | |
UniProtAcc | P02751 | P46527 | |
Ensembl transtripts involved in fusion gene | ENST00000421182, ENST00000357867, ENST00000323926, ENST00000336916, ENST00000354785, ENST00000357009, ENST00000346544, ENST00000345488, ENST00000359671, ENST00000446046, ENST00000443816, ENST00000432072, ENST00000356005, ENST00000490833, ENST00000426059, | ENST00000477087, ENST00000228872, ENST00000396340, | |
Fusion gene scores | * DoF score | 20 X 22 X 6=2640 | 4 X 4 X 2=32 |
# samples | 24 | 4 | |
** MAII score | log2(24/2640*10)=-3.4594316186373 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(4/32*10)=0.321928094887362 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: FN1 [Title/Abstract] AND CDKN1B [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | FN1 | GO:0001932 | regulation of protein phosphorylation | 11792823 |
Hgene | FN1 | GO:0008284 | positive regulation of cell proliferation | 25834989 |
Hgene | FN1 | GO:0010628 | positive regulation of gene expression | 25834989 |
Hgene | FN1 | GO:0018149 | peptide cross-linking | 3997886 |
Hgene | FN1 | GO:0034446 | substrate adhesion-dependent cell spreading | 16236823 |
Hgene | FN1 | GO:0035987 | endodermal cell differentiation | 23154389 |
Hgene | FN1 | GO:0048146 | positive regulation of fibroblast proliferation | 25834989 |
Hgene | FN1 | GO:0051702 | interaction with symbiont | 12167537|12421310|19429745 |
Hgene | FN1 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction | 17849409 |
Hgene | FN1 | GO:0070372 | regulation of ERK1 and ERK2 cascade | 11792823 |
Hgene | FN1 | GO:1904237 | positive regulation of substrate-dependent cell migration, cell attachment to substrate | 25834989 |
Hgene | FN1 | GO:2001202 | negative regulation of transforming growth factor-beta secretion | 25834989 |
Tgene | CDKN1B | GO:0000082 | G1/S transition of mitotic cell cycle | 10208428 |
Tgene | CDKN1B | GO:0008285 | negative regulation of cell proliferation | 19266349 |
Tgene | CDKN1B | GO:0010942 | positive regulation of cell death | 19266349 |
Tgene | CDKN1B | GO:0030308 | negative regulation of cell growth | 10208428 |
Tgene | CDKN1B | GO:0033673 | negative regulation of kinase activity | 19170105 |
Tgene | CDKN1B | GO:0042326 | negative regulation of phosphorylation | 10208428 |
Tgene | CDKN1B | GO:0045732 | positive regulation of protein catabolic process | 19056892 |
Tgene | CDKN1B | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity | 28666995 |
Tgene | CDKN1B | GO:0045892 | negative regulation of transcription, DNA-templated | 19170105 |
Tgene | CDKN1B | GO:0045930 | negative regulation of mitotic cell cycle | 19266349 |
Tgene | CDKN1B | GO:0048102 | autophagic cell death | 12698196 |
Tgene | CDKN1B | GO:0071285 | cellular response to lithium ion | 19056892 |
Tgene | CDKN1B | GO:0071850 | mitotic cell cycle arrest | 19266349 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChiTaRS3.1 | BG925834 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-intron | ENST00000421182 | ENST00000477087 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
5CDS-3UTR | ENST00000421182 | ENST00000228872 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
5CDS-intron | ENST00000421182 | ENST00000396340 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
5CDS-intron | ENST00000357867 | ENST00000477087 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
5CDS-3UTR | ENST00000357867 | ENST00000228872 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
5CDS-intron | ENST00000357867 | ENST00000396340 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
5CDS-intron | ENST00000323926 | ENST00000477087 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
5CDS-3UTR | ENST00000323926 | ENST00000228872 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
5CDS-intron | ENST00000323926 | ENST00000396340 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
5CDS-intron | ENST00000336916 | ENST00000477087 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
5CDS-3UTR | ENST00000336916 | ENST00000228872 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
5CDS-intron | ENST00000336916 | ENST00000396340 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
5CDS-intron | ENST00000354785 | ENST00000477087 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
5CDS-3UTR | ENST00000354785 | ENST00000228872 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
5CDS-intron | ENST00000354785 | ENST00000396340 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
5CDS-intron | ENST00000357009 | ENST00000477087 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
5CDS-3UTR | ENST00000357009 | ENST00000228872 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
5CDS-intron | ENST00000357009 | ENST00000396340 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
5CDS-intron | ENST00000346544 | ENST00000477087 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
5CDS-3UTR | ENST00000346544 | ENST00000228872 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
5CDS-intron | ENST00000346544 | ENST00000396340 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
5CDS-intron | ENST00000345488 | ENST00000477087 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
5CDS-3UTR | ENST00000345488 | ENST00000228872 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
5CDS-intron | ENST00000345488 | ENST00000396340 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
5CDS-intron | ENST00000359671 | ENST00000477087 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
5CDS-3UTR | ENST00000359671 | ENST00000228872 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
5CDS-intron | ENST00000359671 | ENST00000396340 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
5CDS-intron | ENST00000446046 | ENST00000477087 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
5CDS-3UTR | ENST00000446046 | ENST00000228872 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
5CDS-intron | ENST00000446046 | ENST00000396340 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
5CDS-intron | ENST00000443816 | ENST00000477087 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
5CDS-3UTR | ENST00000443816 | ENST00000228872 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
5CDS-intron | ENST00000443816 | ENST00000396340 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
5CDS-intron | ENST00000432072 | ENST00000477087 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
5CDS-3UTR | ENST00000432072 | ENST00000228872 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
5CDS-intron | ENST00000432072 | ENST00000396340 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
5CDS-intron | ENST00000356005 | ENST00000477087 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
5CDS-3UTR | ENST00000356005 | ENST00000228872 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
5CDS-intron | ENST00000356005 | ENST00000396340 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
intron-intron | ENST00000490833 | ENST00000477087 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
intron-3UTR | ENST00000490833 | ENST00000228872 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
intron-intron | ENST00000490833 | ENST00000396340 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
5CDS-intron | ENST00000426059 | ENST00000477087 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
5CDS-3UTR | ENST00000426059 | ENST00000228872 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
5CDS-intron | ENST00000426059 | ENST00000396340 | FN1 | chr2 | 216283967 | - | CDKN1B | chr12 | 12874585 | + |
Top |
FusionProtFeatures for FN1_CDKN1B |
![]() |
Hgene | Tgene |
FN1 | CDKN1B |
Important regulator of cell cycle progression. Inhibitsthe kinase activity of CDK2 bound to cyclin A, but has littleinhibitory activity on CDK2 bound to SPDYA (PubMed:28666995).Involved in G1 arrest. Potent inhibitor of cyclin E- and cyclin A-CDK2 complexes. Forms a complex with cyclin type D-CDK4 complexesand is involved in the assembly, stability, and modulation ofCCND1-CDK4 complex activation. Acts either as an inhibitor or anactivator of cyclin type D-CDK4 complexes depending on itsphosphorylation state and/or stoichometry.{ECO:0000269|PubMed:10831586, ECO:0000269|PubMed:12244301,ECO:0000269|PubMed:16782892, ECO:0000269|PubMed:17254966,ECO:0000269|PubMed:19075005, ECO:0000269|PubMed:28666995}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for FN1_CDKN1B |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for FN1_CDKN1B |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for FN1_CDKN1B |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Hgene | FN1 | P02751 | DB08888 | Ocriplasmin | Fibronectin | biotech | approved |
Hgene | FN1 | P02751 | DB01593 | Zinc | Fibronectin | small molecule | approved|investigational |
Top |
RelatedDiseases for FN1_CDKN1B |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | FN1 | C0020538 | Hypertensive disease | 2 | CTD_human;HPO |
Hgene | FN1 | C0000786 | Spontaneous abortion | 1 | CTD_human |
Hgene | FN1 | C0003504 | Aortic Valve Insufficiency | 1 | CTD_human |
Hgene | FN1 | C0007621 | Neoplastic Cell Transformation | 1 | CTD_human |
Hgene | FN1 | C0010346 | Crohn Disease | 1 | CTD_human |
Hgene | FN1 | C0011849 | Diabetes Mellitus | 1 | CTD_human |
Hgene | FN1 | C0011881 | Diabetic Nephropathy | 1 | CTD_human |
Hgene | FN1 | C0017636 | Glioblastoma | 1 | CTD_human |
Hgene | FN1 | C0017668 | Focal glomerulosclerosis | 1 | CTD_human |
Hgene | FN1 | C0024667 | Animal Mammary Neoplasms | 1 | CTD_human |
Hgene | FN1 | C0024668 | Mammary Neoplasms, Experimental | 1 | CTD_human |
Hgene | FN1 | C0027626 | Neoplasm Invasiveness | 1 | CTD_human |
Hgene | FN1 | C0034069 | Pulmonary Fibrosis | 1 | CTD_human |
Hgene | FN1 | C0036341 | Schizophrenia | 1 | PSYGENET |
Hgene | FN1 | C0085762 | Alcohol abuse | 1 | PSYGENET |
Hgene | FN1 | C0149721 | Left Ventricular Hypertrophy | 1 | CTD_human |
Hgene | FN1 | C0345967 | Malignant mesothelioma | 1 | CTD_human |
Hgene | FN1 | C1458155 | Mammary Neoplasms | 1 | CTD_human |
Hgene | FN1 | C1866075 | GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 2 (disorder) | 1 | UNIPROT |
Tgene | CDKN1B | C0024121 | Lung Neoplasms | 3 | CTD_human |
Tgene | CDKN1B | C0033578 | Prostatic Neoplasms | 2 | CTD_human |
Tgene | CDKN1B | C0021841 | Intestinal Neoplasms | 1 | CTD_human |
Tgene | CDKN1B | C0022665 | Kidney Neoplasm | 1 | CTD_human |
Tgene | CDKN1B | C0023903 | Liver neoplasms | 1 | CTD_human |
Tgene | CDKN1B | C0025500 | Mesothelioma | 1 | CTD_human |
Tgene | CDKN1B | C0032019 | Pituitary Neoplasms | 1 | CTD_human |
Tgene | CDKN1B | C0034885 | Rectal Neoplasms | 1 | CTD_human |
Tgene | CDKN1B | C0036920 | Sezary Syndrome | 1 | CTD_human |
Tgene | CDKN1B | C0038356 | Stomach Neoplasms | 1 | CTD_human |
Tgene | CDKN1B | C0042138 | Uterine Neoplasms | 1 | CTD_human |
Tgene | CDKN1B | C0079487 | Helicobacter Infections | 1 | CTD_human |
Tgene | CDKN1B | C0206669 | Hepatocellular Adenoma | 1 | CTD_human |
Tgene | CDKN1B | C0206754 | Neuroendocrine Tumors | 1 | CTD_human |
Tgene | CDKN1B | C0263454 | Chloracne | 1 | CTD_human |
Tgene | CDKN1B | C0282612 | Prostatic Intraepithelial Neoplasias | 1 | CTD_human |
Tgene | CDKN1B | C0919267 | ovarian neoplasm | 1 | CTD_human |
Tgene | CDKN1B | C1458155 | Mammary Neoplasms | 1 | CTD_human |
Tgene | CDKN1B | C2239176 | Liver carcinoma | 1 | CTD_human |